193 related articles for article (PubMed ID: 6305532)
1. The influence of molecular form of local anesthetic-type antiarrhythmic agents on reduction of the maximum upstroke velocity of canine cardiac Purkinje fibers.
Gintant GA; Hoffman BF; Naylor RE
Circ Res; 1983 Jun; 52(6):735-46. PubMed ID: 6305532
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Vmax by QX-314 and benzocaine in neonatal and adult canine cardiac Purkinje fibers.
Spinelli W; Danilo P; Rosen MR
J Pharmacol Exp Ther; 1988 Apr; 245(1):381-7. PubMed ID: 3361451
[TBL] [Abstract][Full Text] [Related]
3. Use-dependent block of cardiac sodium channels by quaternary derivatives of lidocaine.
Gintant GA; Hoffman BF
Pflugers Arch; 1984 Feb; 400(2):121-9. PubMed ID: 6326044
[TBL] [Abstract][Full Text] [Related]
4. Modification of the frequency- and voltage-dependent effects of quinidine when administered in combination with tocainide in canine Purkinje fibers.
Valois M; Sasyniuk BI
Circulation; 1987 Aug; 76(2):427-41. PubMed ID: 2440617
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction.
Kinnaird AA; Man RY
Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761
[TBL] [Abstract][Full Text] [Related]
6. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
Nattel S
J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
[TBL] [Abstract][Full Text] [Related]
7. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
Varro A; Elharrar V; Surawicz B
J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
[TBL] [Abstract][Full Text] [Related]
8. Effects of lidocaine and on slow response and depressed fast response action potentials of canine cardiac Purkinje fibers.
Brennan FJ; Cranefield PF; Wit AL
J Pharmacol Exp Ther; 1978 Feb; 204(2):312-24. PubMed ID: 621666
[TBL] [Abstract][Full Text] [Related]
9. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.
Kinnaird AA; Man RY
Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981
[TBL] [Abstract][Full Text] [Related]
10. Cellular electrophysiology of the new antiarrhythmic agent recainam (Wy-42,362) in canine cardiac Purkinje fibers.
Colatsky TJ; Bird LB; Jurkiewicz NK; Wendt RL
J Cardiovasc Pharmacol; 1987 Apr; 9(4):435-44. PubMed ID: 2438506
[TBL] [Abstract][Full Text] [Related]
11. Barucainide, a novel class Ib antiarrhythmic agent with a slow kinetic property: electrophysiologic observations in isolated canine and rabbit cardiac muscle.
Takanaka C; Singh BN
Am Heart J; 1990 May; 119(5):1050-60. PubMed ID: 2330863
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
Brown BS
J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
[TBL] [Abstract][Full Text] [Related]
13. Modification of Vmax of canine cardiac Purkinje fibers and of the effects of lidocaine by SC-72-14.
Morikawa Y; Meiri H; Spinelli W; Rosen MR; Robinson RB
Circ Res; 1985 Sep; 57(3):354-61. PubMed ID: 2411443
[TBL] [Abstract][Full Text] [Related]
14. Modification of the electrophysiologic matrix by antiarrhythmic drugs.
Hoffman BF
J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):28B-30B. PubMed ID: 3923078
[TBL] [Abstract][Full Text] [Related]
15. Frequency-dependent actions of phenytoin in adult and young canine Purkinje fibers.
Spinelli W; Rosen MR
J Pharmacol Exp Ther; 1986 Sep; 238(3):794-801. PubMed ID: 3746664
[TBL] [Abstract][Full Text] [Related]
16. Local anesthetics QX 572 and benzocaine act at separate sites on the batrachotoxin-activated sodium channel.
Huang LM; Ehrenstein G
J Gen Physiol; 1981 Feb; 77(2):137-53. PubMed ID: 6267160
[TBL] [Abstract][Full Text] [Related]
17. Sites of action and active forms of lidocaine and some derivatives on cardiac Purkinje fibers.
Gliklich JI; Hoffman BF
Circ Res; 1978 Oct; 43(4):638-51. PubMed ID: 688563
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues.
Steinberg MI; Wiest SA
J Cardiovasc Pharmacol; 1984; 6(4):614-21. PubMed ID: 6206315
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.
Qu Y; Rogers J; Tanada T; Scheuer T; Catterall WA
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11839-43. PubMed ID: 8524860
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic properties of a new antiarrhythmic drug--tocainide.
Moore EN; Spear JF; Horowitz LN; Feldman HS; Moller RA
Am J Cardiol; 1978 Apr; 41(4):703-9. PubMed ID: 645575
[No Abstract] [Full Text] [Related]
[Next] [New Search]
